Immuron CEO reports initial shareholdings
Immuron Ltd’s Chief Executive Officer Steven George Lydeamore has filed an initial ownership report.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
Immuron Ltd’s Chief Executive Officer Steven George Lydeamore has filed an initial ownership report. He directly holds 3,155,047 Ordinary Shares. He also holds 1,778,734 Performance Rights that vest upon achievement of performance milestones and options over 1,430,000 Ordinary Shares with a USD exercise price of $0.0861 per share, expiring on June 27, 2026.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Lydeamore Steven George
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Options | -- | -- | -- |
| holding | Performance Rights | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Options — 1,430,000 contracts (Direct);
Performance Rights — 1,778,734 contracts (Direct);
Ordinary Shares — 3,155,047 shares (Direct)
Footnotes (2)
- F1. Vest upon achievement of performance milestones.
- F2. The exercise price of this option, originally denominated in Australian dollar ("AUD") in the amount of AUD $0.120 is presented in the table in U.S.dollars ("USD") based on the exchange rate reported by the Reserve Bank of Australia on April 28, 2026, which was AUD 1.00 = USD 0.7172.
Key Figures
Ordinary Shares held: 3,155,047 shares
Performance Rights underlying shares: 1,778,734 shares
Options underlying shares: 1,430,000 shares
+3 more
6 metrics
Ordinary Shares held
3,155,047 shares
Direct ownership reported on Form 3
Performance Rights underlying shares
1,778,734 shares
Vest upon achievement of performance milestones; expire June 30, 2029
Options underlying shares
1,430,000 shares
Directly held options over Ordinary Shares
Option exercise price
$0.0861 per share
Converted from AUD 0.120 using RBA rate on April 28, 2026
Option expiration date
June 27, 2026
Expiration of options over 1,430,000 Ordinary Shares
Performance Rights expiration date
June 30, 2029
Expiration of Performance Rights over 1,778,734 underlying shares
Key Terms
Performance Rights, Options, exercise price, expiration date, +1 more
5 terms
Performance Rights financial
"The CEO also holds 1,778,734 Performance Rights that vest upon achievement of performance milestones"
Performance rights are conditional awards that give employees or executives the promise of receiving company shares or cash only if the business meets specific targets or survives for a set period. They work like a bonus you only get when certain goals are hit, so they matter to investors because they can increase the number of shares outstanding (dilution), signal management’s incentives and confidence in future results, and affect per-share earnings and valuation.
Options financial
"He also holds options over 1,430,000 Ordinary Shares with a USD exercise price"
Options are contracts that give investors the right to buy or sell an asset at a specific price within a certain time frame. They function like a reservation or a ticket that allows for potential profit or protection against price changes, making them useful tools for managing investment risks or speculating on market movements.
exercise price financial
"These options carry an exercise price of $0.0861 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"These options carry an exercise price of $0.0861 per share and have an expiration date of June 27, 2026"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Immuron (IMRN) CEO Steven Lydeamore report owning in this Form 3?
Steven Lydeamore reports direct ownership of 3,155,047 Ordinary Shares of Immuron Ltd. He also holds 1,778,734 Performance Rights and options over 1,430,000 Ordinary Shares, providing additional potential equity exposure if performance conditions are met and options are exercised.
How many Performance Rights does the Immuron (IMRN) CEO hold and how do they vest?
The CEO holds 1,778,734 Performance Rights linked to Immuron Ordinary Shares. According to the filing, these Performance Rights vest upon achievement of specified performance milestones, meaning they convert to shares only if those operational or financial targets are met during the performance period.
What option holdings does the Immuron (IMRN) CEO disclose in this Form 3?
The filing shows options over 1,430,000 Immuron Ordinary Shares held directly by the CEO. These options carry an exercise price of $0.0861 per share and have an expiration date of June 27, 2026, after which any unexercised options lapse.
What is the exercise price and currency basis for the Immuron (IMRN) CEO stock options?
The CEO’s options have an exercise price of $0.0861 per Ordinary Share, presented in U.S. dollars. A footnote explains this reflects an original Australian dollar price of AUD 0.120, converted using the Reserve Bank of Australia’s April 28, 2026 exchange rate.
Do the Immuron (IMRN) Performance Rights held by the CEO have an expiration date?
Yes. The filing states the Performance Rights held by the CEO, linked to 1,778,734 underlying Ordinary Shares, have an expiration date of June 30, 2029. They vest only upon achievement of specified performance milestones before that expiry, otherwise they will not convert into Ordinary Shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates